Several well-accepted stroke assessment scales have been developed for use in clinical settings such as Stroke Impact Scale (SIS), Fugl-Meyer Assessment for the Upper Extremity and Lower Extremity (FMA-UE and FMA-LE), Berg Balance Score (BBS), Modified Ranking Scale (MRS), and the global rating of change scale (GROC). However, clinical outcomes were assessed by patient self-evaluation and physiotherapists, responsiveness and discrimination of high and low disability in the context of functional recovery have not yet been confirmed. The purpose of this study was to 1) compare the Stroke Impact Scale (SIS) and clinical outcomes between the baseline and after the 12-week physical therapy treatment program and 2) to investigate the correl...
Problem. Stroke is the third common cause of mortality in developed countries (Dias et al., 2007). S...
The effectiveness of therapeutic interventions in acute stroke trials is traditionally measured with...
Background and Purpose—There is a lack of agreement regarding measuring the effects of stroke treatm...
Background. The motor function section of the Fugl-Meyer assessment scale (FM motor scale) is a robu...
Background: This study was conducted to establish the minimal detectable change MDC and clinically i...
Jennifer K Harrison,1 Katherine S McArthur,2 Terence J Quinn21Department of Cardiovascular Sciences,...
BACKGROUND AND PURPOSE: Evaluating the impact of new treatments requires the use of reliable, valid,...
With stroke being the leading global cause of disability in adults, the use of clinical rating scale...
BackgroundAbout half of survivors with stroke experience severe and significant long-term disability...
Objective. To provide empirical justification for selecting motor scales for stroke patients, the au...
Stroke is one of the major causes of morbidity and mortality. Sequels deriving from this event may l...
Background and objectivesPrecise measurement of outcomes is essential for stroke trials and clinical...
and the upper extremity motor section of the Fugl-Meyer Assessment (FMA) scale were compared in a co...
Abstract—Although most current stroke intervention trials use disability scales to determine outcome...
Background: The Stroke Impact Scale 3.0 (SIS 3.0) is widely used to measure quality of life in strok...
Problem. Stroke is the third common cause of mortality in developed countries (Dias et al., 2007). S...
The effectiveness of therapeutic interventions in acute stroke trials is traditionally measured with...
Background and Purpose—There is a lack of agreement regarding measuring the effects of stroke treatm...
Background. The motor function section of the Fugl-Meyer assessment scale (FM motor scale) is a robu...
Background: This study was conducted to establish the minimal detectable change MDC and clinically i...
Jennifer K Harrison,1 Katherine S McArthur,2 Terence J Quinn21Department of Cardiovascular Sciences,...
BACKGROUND AND PURPOSE: Evaluating the impact of new treatments requires the use of reliable, valid,...
With stroke being the leading global cause of disability in adults, the use of clinical rating scale...
BackgroundAbout half of survivors with stroke experience severe and significant long-term disability...
Objective. To provide empirical justification for selecting motor scales for stroke patients, the au...
Stroke is one of the major causes of morbidity and mortality. Sequels deriving from this event may l...
Background and objectivesPrecise measurement of outcomes is essential for stroke trials and clinical...
and the upper extremity motor section of the Fugl-Meyer Assessment (FMA) scale were compared in a co...
Abstract—Although most current stroke intervention trials use disability scales to determine outcome...
Background: The Stroke Impact Scale 3.0 (SIS 3.0) is widely used to measure quality of life in strok...
Problem. Stroke is the third common cause of mortality in developed countries (Dias et al., 2007). S...
The effectiveness of therapeutic interventions in acute stroke trials is traditionally measured with...
Background and Purpose—There is a lack of agreement regarding measuring the effects of stroke treatm...